Publications
May 11, 2021

VOR33: A Clinic-Ready CRISPR/Cas9 Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia

Platform, Trem-cel
Presented by: John R. Lydeard, PhD – Discovery and Molecular Engineering – Vor Bio

ASGCT – 2021 – Oral Presentation